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It has been established that Picralima nitida has antitussive effect. This study therefore aimed at deter-
mining the possible mode of antitussive and expectorant activity of an ethanolic seed extract of P. nitida
(PNE). The muco-suppressant, mast cell stabilization, and the anxiolytic effects of PNE were ascertained
using ammonium chloride-induced phenol red secretion in BALB/c mice; compound 48/80-induced
mesenteric mast cell degranulation assay; and the open ﬁeld and the elevated plus maze models
respectively. Antibacterial potential was ascertained by the agar plate diffusion method and its antiox-
idant potential by the 2,2-diphenyl-1-picrylhydrazyl hydrate (DPPH) free radical scavenging, linoleic acid
lipid peroxidation, reducing power, and total antioxidant assays. Data obtained was analyzed using One-
way analysis of variance (ANOVA) with Dunnett's Multiple Comparison post hoc test. PNE (100e500 mg/
kg) reduced (P  0.05e0.001) tracheal phenol red secretion. The extract (100e500 mg/ml) also dose-
dependently (P  0.05e0.0001) stabilized mast cells. PNE (100e500 mg/kg) increased open arm activ-
ities in the elevated plus maze (P  0.05) as well as central zone exploration (P  0.05) in the open ﬁeld
test. PNE (10e50 mg/ml) showed activity against Staphylococcus aureus, Streptococcus pneumonia,
Escherichia coli, Klebsiella pneumonia, and Salmonella typhi. By the assays, PNE showed signiﬁcant anti-
oxidant effect. The ethanolic seed extract of P. nitida has demonstrated very signiﬁcant mast cell stabi-
lizing, mucus suppressant, and antioxidant activity as well as substantial antibacterial and anxiolytic
properties; all of which could contribute to its antitussive and expectorant property.
Copyright © 2016, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Antitussives are pharmacological agents that suppress the
cough reﬂex.1 They act via mechanisms classiﬁed as central or pe-
ripheral; though some act through both pathways.1 The antitussive
effect of an ethanolic seed extract of Picralima nitida (PNE) has
previously been established by the authors.2 However, the mode of
activity of cough medicines could be attributed to at least ﬁve
reasons: pharmacological, physiological, true placebo,G. Dapaah), gkoffuor@yahoo.
Mante), hpbee1@yahoo.com
for Food and Biomolecules,
molecules, National Taiwan Unive
ons.org/licenses/by-nc-nd/4.0/).psychological and non-speciﬁc action. Plant/plant products exhib-
iting antitussive activity may not have one mode of expressing this
pharmacological effect.3,4 The purport of this study was to establish
the possible mode of antitussive and expectorant activity of an
ethanolic seed extract of P. nitida. This will be ascertained by;
evaluating muco-suppression effect, assessing mast cell stabiliza-
tion effect, and establishing antibacterial, anxiolytic, antioxidant
activity in various rodent models.2. Materials and methods
2.1. Plant collection and extraction
The pods of P. nitida were collected from the KNUST botanical
garden in Kumasi, Ghana, in February, 2013. Authentication was
done at the Department of Pharmacognosy, KNUST. The pods werersity. Production and hosting by Elsevier Taiwan LLC. This is an open access article
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powderweighing four (4) kgwas extracted by coldmacerationwith
70% ethanol over a period of 72 h. The resulting extract was then
concentrated at a temperature of 40 C and under low pressure to a
syrupy mass in a rotary evaporator (Rotavapor R-210, Buchi,
Switzerland). The syrupy mass obtained was then dried in a hot air
oven (Gallenkamp, UK) maintained at 40 C to obtain 0.532 kg (%
yield: 13.3%) of a solid mass of P. nitida extract (PNE).
2.2. Drugs and chemicals
Sodium cromoglycate (Ashford Laboratory Ltd., Macau);
ammonium chloride (Philip Harris, Hyde-Cheshire; UK); Phenol red
and sodium chloride (BDH Chemicals Ltd, Poole, England); Ketoti-
fen fumarate (Novartis Pharma AG, Basle, Switzerland); Compound
48/80 and toluidine blue (Sigma Chemical Co., St. Louis, MO, USA);
Sodium hydroxide (Avondale, England); Acetic acid, Diazepam
(SigmaeAldrich Inc., St. Louis, MO, USA), Caffeine (SigmaeAldrich
Inc., St. Louis, MO, USA) were used in this study.
2.3. Animals
BALB/c mice (20e30 g) and a SpragueeDawley rat (130 g), ob-
tained from the animal house of the Department of Pharmacology,
KNUST, Kumasi, Ghana were used in this study. They were fed on
standard rodent pellet diet (Agricare Ltd, Tanoso, Kumasi, Ghana)
and water ad libitum. The animals were kept in the experimental
area of the Departmental animal house at ambient conditions of
light, temperature and humidity for seven (7) days prior to exper-
imentation and during experimentation.
2.4. Muco-suppressant effect of PNE
The muco-suppressant effect of PNE was determined using the
ammonium chloride-induced tracheal phenol red secretion model;
described previously.5 BALB/c mice were put into ﬁve groups, IeV,
(n ¼ 5) and pre-treated, for 30 min, as follows: Group I, two (2) ml/
kg normal saline (p.o); Group II, 100 mg/kg Sodium cromoglycate
(i.p); Groups IIIeV, 100, 300, and 500 mg/kg of PNE (p.o) respec-
tively. Tracheal mucus secretionwas then induced with ﬁve (5) mg/
kg ammonium chloride per os. Animals were then injected with
500 mg/kg phenol red, intraperitoneally, 30 min later. The trachea
was excised from each mouse and cleared of adhering tissues, after
sacriﬁcing it by cervical dislocation (30 min after the phenol red
injection). Each excised trachea was washed in three (3) ml phys-
iological saline; sodium hydroxide (0.3 ml NaOH, one (1) M) was
then added to the washing to stabilize the pH of the lavage ﬂuid.
The absorbance of the mixture was then taken at a wavelength of
460 nm using a spectrophotometer (T90 þ UV/VIS Spectrometer e
PG Instruments Ltd). A calibration curve for phenol red was made;
fromwhich concentrations of phenol red secreted bymice tracheae
were extrapolated.
2.5. Compound 48/80-induced mesenteric mast cell degranulation
Mast cell stabilizing effect was ascertained using compound 48/
80-induced mesenteric mast cell degranulation as described pre-
viously.6 SpragueeDawley rat intestinal mesenteries was excised
into several pieces and put into ﬁve groups, G1eG5 (n ¼ 5), in petri
dishes containing tyrode solution. The mesenteries were then
subjected to the following treatment: G1, normal saline; G2, 20 mg/
ml ketotifen fumarate; G3eG5, 100, 300, and 500 mg/ml PNE
respectively. The petri dishes were then incubated at 37 C for
15 min after which one (1) ml of compound 48/80 solution (10 mg/
ml) was added and incubated at 37 C for ten (10) min. Themesenteric pieces were then ﬁxed in 10 % buffered formalin and
processed in xylene and acetone. They were then stained with 0.1 %
toluidine blue and observed under a Leica DM 750 microscope
(Leica Microsystems CM5 GmbH, Wetzlar e Germany) for both
intact and degranulated cells. The percentage mast cell degranu-
lation for each treatment was estimated.2.6. Antibacterial property of PNE
The antibacterial property of PNE was investigated using the
agar well diffusion method.7 Ten (10) test tubes (labeled T1eT10)
each containing 20 ml nutrient agar were stabilized. The molten
agars were inoculated with 0.2 ml each of the following organisms:
T1 and T2, Staphylococcus aureus; T3 and T4, Streptococcus pneu-
monia; T5 and T6, Salmonella typhi; T7 and T8, Escherichia coli; T9
and T10, Klebsiella pneumonia. The seeded agars were poured into
labeled sterile petri dishes (P1eP10) and allowed to set. Using a
sterile cork borer number seven (7), ﬁve wells were created in each
of the ten petri dishes. Various concentrations of PNE were pre-
pared and poured in the wells to three-quarter (3/4) full as follows:
P1, P3, P5, P7 and P9 each received 0.05, 0.5, 5, 25 mg/ml PNE, while
P2, P4, P6, P8 and P10 received 0.1, 1, 10, 50 mg/ml PNE, in four of
the ﬁvewells created. The petri dishes were covered and left on the
bench for 45 min in order to allow effective diffusion of the extract.
They were then incubated at 37 C for 24 h, after which they were
examined for zones of growth inhibition around the wells. Amox-
icillin (1 %) was used as a positive control in the test against S.
aureus, S. pneumonia, E. coli and K. pneumonia. Ciproﬂoxacin (0.1 %)
was the control in the test against S. typhi. The test was carried out
in triplicate.2.7. Anxiolytic effect of PNE
2.7.1. Elevated plus maze
This test has widely been used to measure anxiety in rodents
especially mice.8 The apparatus was made of plexiglas and con-
sisted of two open arms and two closed arms of dimensions
30 cm  5 cm  15 cm. These arms extend from a central square
platform (5 cm 5 cm). The mazewas elevated to a height of 60 cm
above the ﬂoor and placed in a lit room. Mice were divided into ten
groups (n ¼ 6) and received the following treatment: vehicle-
control, PNE (100, 300, 500 mg/kg), Diazepam (0.1, 0.3, 1.0 mg/
kg), and Caffeine (3, 10, 30 mg/kg). Diazepam and caffeine served as
reference anxiolytic and anxiogenic drugs respectively. The vehicle,
PNE, caffeine were orally administered to their respective animals'
an hour before the experiment, whiles diazepam was given intra-
peritoneally 30 min before the experiment. At the start of the
experiment, animals were individually placed at the center of the
maze, facing one of the enclosed arms and their behavior video-
taped for 5 min with a digital camera placed 100 cm above the
maze. After each test, the maze was carefully cleaned up with 10%
ethanol solution. Behavioral parameters were scored from the
videotapes as follows:
1) number of closed and open arm entriesd(absolute value and
percentage of the total number);
2) time spent in exploring the open and closed arms of the
mazedabsolute time and percentage of the total time of testing
3) number of head-dips (absolute value and percentage of the total
number)dprotruding the head over the ledge of either an open
(unprotected) or closed (protected) arm and down toward the
ﬂoor;
4) number of stretch-attend postures (absolute value and per-
centage of the total number)dthe mouse stretches forward and
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(unprotected) arm.
The behavior was tracked by JWatcher™ Version 1.0 (University
of California, Los Angeles, USA and Macquarie University, Sidney,
Australia; available at http://www.jwatcher.ucla.edu/.)
2.7.2. Open ﬁeld
The open ﬁeld method has previously been described.9 The test
was conducted in clear plexiglas boxes (40 cm  40 cm  30 cm).
The ﬂoor of this box was divided by red lines into 16 equal squares.
For behavioral analysis, the arena of the open ﬁeld was designated
as;
1) corner (one of the four corner squares);
2) periphery (the squares along the walls); or
3) center (the four inner squares).
The animals were divided into ten groups (n ¼ 6), and
received either the extracts (100, 300, or 500 mg/kg, p.o.), the
vehicle or the reference drug diazepam (0.1, 0.3 or 1 mg/kg, i.p.).
Thirty minutes after i.p and 1 h after oral administration, the
animals were placed at the center of the open ﬁeld and were
allowed to explore for 5 min. This was recorded by a video
camera which was suspended 100 cm above the arena. Behav-
ioral parameters for all the tests were scored from videotapes
with the aid of the public domain software JWatcher™ Version
1.0. The numbers of entries, as well as the duration of stay in
individual zones were assessed.
2.8. Antioxidant property of PNE
The antioxidant property of PNE (0.1e30 mg/ml) was evaluated
in 2, 2-diphenyl-1-picrylhydrazyl hydrate (DPPH) free radical
scavenging, linoleic acid lipid peroxidation, reducing power, and
total antioxidant assays by standard procedures previously
described by Amoateng et al., 2011.10
2.9. Data analysis
Data obtained in all experiments were expressed as
mean ± SEM. Statistical analyses were done by one-way analysis of
variance (ANOVA) with Dunnett's Multiple Comparison test (post
hoc test) using Graph-Pad Prism for Windows Version 6.0 (Graph-
Pad Software, San Diego, CA, USA). Some aspects of the open ﬁeld
and elevated plus maze were done with two-way analysis of vari-
ance followed by Bonferroni's post-hoc test. Differences between
means of treated groups and the control were regarded as statis-
tically signiﬁcant at P  0.05.
3. Results
3.1. Muco-suppressant and mast cell stabilizing effect of PNE
Sodium cromoglycate, and PNE (100e300 mg/kg) signiﬁcantly
(P  0.05e0.001) reduced tracheal phenol red secretion compared
to the control (Fig. 1a). Treatments with ketotifen fumarate, and
PNE (100e500 mg/kg) were also able to reduce signiﬁcantly
(P  0.05e0.001) inhibit mast cell degranulation induced by com-
pound 48/80 (Fig. 1b).
3.2. Antibacterial effects
Signiﬁcant (P  0.05e0.0001) antibacterial activity was
observed E. coli, S. typhi, K. pneumonia, S. pneumonia, and S. aureusfrom 10e50 mg/ml. The lowest effect was against S. typhi at 5 mg/
ml with a zone of 13.0 ± 0.00 mmwhiles the highest response was
observed against S. pneumonia at 50 mg/ml with a zone of
22.3 ± 0.88 mm (Table 1).
3.3. Anxiolytic effect of PNE
3.3.1. Elevated plus maze
PNE (100, 300, 500 mg/kg) enhanced, dose-independently, ac-
tivities in the open arm by increasing percentage of entry into open
arms (P  0.0001; Fig. 2f) and percentage time spent in open arms
(P¼ 0.1278; Fig. 2c). There was also reduction in risk assessment by
decreasing both the percentage protected head dips (P ¼ 0.0030;
Fig. 3c) and percentage protected stretch attend postures
(P ¼ 0.0860; Fig. 3f). Diazepam (0.1e1 mg/kg) also dose depen-
dently and signiﬁcantly increased percentage of open arm entries
(P ¼ 0.0005; Fig. 2e) and percentage time spent in open arm
(P ¼ 0.0004; Fig. 2b). Diazepam also reduced risk assessment by
decreasing both the percentage protected head dips (P ¼ 0.0002;
Fig. 3b) and percentage protected stretch attend postures
(P ¼ 0.0192; Fig. 3e). These effects conﬁrmed the anxiolytic effects
of both PNE and diazepam. With regard to caffeine, it increased
open arm avoidance by reducing percentage of open arm entries
(P ¼ 0.8997; Fig. 2d) and percentage time spent in open arms
(P ¼ 0.0285; Fig. 2a). Also, caffeine increased both the percentage
protected head dips (P ¼ 0.7205; Fig. 3a) and percentage protected
stretch attend postures (P ¼ 0.0247; Fig. 3d), all indicative of anx-
iogenic effect.
3.3.2. Open ﬁeld
PNE (100, 300, 500 mg/kg) dose-independently increased the
percentage entry into central zone (P ¼ 0.0201; Fig. 4d) and per-
centage time spent in central zones (P ¼ 0.0427; Fig. 4b). These
observations support the claim that PNE acts as an anxiolytic. The
reference anxiolytic, diazepam (0.1e1 mg/kg) dose dependently
increased the percentage entry into central zone (P ¼ 0.0023;
Fig. 4c) and percentage time spent in central zones (P ¼ 0.0603;
Fig. 4a).
3.4. Antioxidant activity
The reference antioxidant, n-propyl gallate (0.001e0.1 mg/ml),
and PNE (0.1e30 mg/ml) exhibited DPPH free radical scavenging
effect (Fig. 5a), and showed concentration dependent ability to
inhibit the autoxidation of linoleic acid lipid peroxidation (Fig. 5b).
PNE and n-propyl gallate also dose dependently reduced Fe3þ to
Fe2þ in the reducing power assay (Fig. 5c). PNE (0.1e30 mg/ml)
showed a concentration dependent increase in total antioxidant
capacity expressed as ascorbic acid equivalent (AAE) (Fig. 5d). EC50
values for the reference antioxidants and PNE are as shown in
Table 2.
4. Discusssion
This study carried out on PNE to determine muco-suppressant,
antibacterial, mast cell stabilizing, anxiolytic, and antioxidant
properties in a bid to establish its mode of activity in the man-
agement of cough evolved from previous work on PNE, by the au-
thors, which established antitussive, and expectorant properties of
the extract.2 Tracheal mucus secretion, mast cell degranulation,
bacterial infection of the airways, psychogenic factors (e.g. anxiety)
and oxidative stress could culminate into cough.
Sodium cromoglycate and PNE signiﬁcantly reduced tracheal
phenol red secretion after ammonium chloride induction, indi-
cating muco-suppressant activity. Sodium cromoglycate is known
Treatments (mg/kg)
Ph
en
ol
 re
d
co
ne
nt
ra
tio
n 
(μ
g/
m
l)
NS
 10
0 S
CG
10
0 P
NE
30
0 P
NE
50
0 P
NE
0
1
2
3
***
*
**
a
Treatments (mg/kg)
%
 M
as
t C
el
l
D
eg
ra
nu
la
tio
n
NS
10
 K
TF
10
0 P
NE
 
30
0 P
NE
 
50
0 P
NE
0
20
40
60
80
100
b
***
*
**
****
Fig. 1. Effect of PNE on (a) ammonium chloride-induced tracheal phenol red secretion as a measure of muco-suppressant effect and (b) mast cell degranulation induced by
Compound 48/80. Values plotted are means ± SEM; (n ¼ 4). ns implies ****P > 0.05; ***P  0.001; **P  0.01; *P  0.05 compared to vehicle-treated group.
Table 1
Effect of 0.05e50 mg/ml PNE on Escherichia coli, Salmonella typhi, Klebsiella pneumoniae, Streptococcus pneumonia and Staphylococcus aureus
Conc. (mg/ml) S. aureus S. pneumonia S. typhi E. coli K. pneumoniae
0.05e1 e e e e e
5 14.67 ± 0.33 14.00 ± 0.00 13.00 ± 0.000 e e
10 17.00 ± 0.58* 15.33 ± 0.33ns 15.00 ± 0.56ns 13.33 ± 0.33 14.33 ± 0.33
25 18.67 ± 0.88** 17.67 ± 0.67** 17.67 ± 0.88*** 14.00 ± 1.16ns 16.00 ± 0.00**
50 20.00 ± 0.00*** 22.33 ± 0.88**** 19.33 ± 0.33*** 16.67 ± 0.33* 17.67 ± 0.33***
Values quoted as zones of inhibitions aremeans± SEM; n¼ 3. (e) indicates “no zones of inhibitionwere observed”. Diameter of borer: 11mm. ns P> 0.05, *P 0.05, **P 0.01,
***P  0.001, ****P  0.0001.
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ﬂammatorymediators11 resulting from chronic inﬂammation of the
airways. The importance of this result lies in the fact that mucus in
the airways mechanically stimulates and increases rapidly thea
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Table 2
EC50 values for the reference antioxidants and PNE in an antioxidant assay.
DPPH LALP RP
n-propyl gallate 4.821  103 5.906  103 4.195  103
PNE 0.8386 0.3975 0.2216
DPPH ¼ 2,2-diphenyl-1-picrylhydrazyl hydrate (DPPH) free radical scavenging
assay; LALP ¼ Linoleic acid lipid peroxidation assay; RP ¼ Reducing power,
TAC ¼ Total antioxidant assay.
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antitussive effect.
Compound 48/80-induced mast cell degranulation is used to
test mast cell stabilizing effects of potential therapeutic agents.
Compound 48/80 causes mast cell degranulation by increasing
intracellular Ca2þ.14 Reduction in number of degranulated mast cell
is a measure of mast cell stabilization. Ketotifen and PNE signiﬁ-
cantly stabilized mast cells. Ketotifen stabilizes mast cells by
inhibiting the release of histamine, serotonin and other inﬂam-
matory mediators.15 Mast cell stabilization could contribute to
antitussive effect in that leukotriene and histamine (which can
stimulate C-ﬁbers) are not release.16 Apart from such direct effect,
leukotrienes and histamine can induce mucus secretion and
bronchoconstriction which can in turn stimulate RAR receptors.
Mast cell stabilization also reduces chronic inﬂammation of the
airway which can lead to hypertrophy and hyperplasia of surface
goblet (mucous) cells and sub-mucosal glands, which consequently
increases mucus production.
PNE demonstrated antibacterial activity against two gram pos-
itive and three gramnegative bacteria, indicating a possible remedy
for cough arising from bacterial infection of the airway. Chronic
cough could be a post infectious cough of viral or bacterial origin.17
Increase in cough sensitivity seems to be the most likely reason
why infection contributes to cough.18 Treatment and/or prevention
of airway infection could be an important way of reducing
inﬂammation and hyper-secretion and hence cough sensitivity.
Antibiotics are usually considered ‘mucoregulatory medications’
when used to treat respiratory infection.19 It is worth noting thatthere could be a potential reduction in C-ﬁber stimulation as a
result of anti-bacterial effect. Bacterial infection is known to reduce
the level of endopeptisase20 especially substance P which gets
released from C-ﬁber. Considering the fact that substance P can
augment C-ﬁber activity21 and that of the RAR through mucus
secretion and bronchospasm it induces suppressing bacterial pro-
liferation will enhance the level of endopeptidase, which in turn
will reduce substance P mediated events.22
Anxiety in particular has been found to be an independent risk
factor for both productive and non-productive cough. This may
reﬂect a somatic manifestation of a wide range of psychological
problems, an increased awareness of physical symptoms in anxious
individuals as well as difﬁculty in maintaining voluntarily cough
suppression.23,24 Therapeutically, therefore, anxiolytics may help to
relieve cough. Psychogenic cough is generally regarded as a respi-
ratory tic and may be precipitated by a variety of emotional stim-
uli.25 In an attempt to establish the fact that PNE could be useful in
managing anxiety-related cough, its anxiolytic effect was estab-
lished using the elevated plus maze and the open ﬁeld tests. The
open-ﬁeld test examines anxiety-related behavior characterized by
avoidance of an open, brightly lit area by rodents.26 Animals placed
in a novel environment express anxiety and fear, by showing
alteration in certain parameters, such as decreases in ambulation
and exploration time in the center of the open ﬁeld with an
attendant increased peripheral movement.27 These behaviors are
attenuated by classical anxiolytics, and potentiated by anxiogenic
agents. The elevated plus maze utilizes the fear of a novel, brightly
lit open space and fear of balancing on a relatively narrow, raised
platform. This is considered a natural stimulus because it can
induce anxiety even in humans.28 Generally, anxiolytics increase
the number of entries into and the time spent in the open arms of
the EPM. This was the case with PNE pointing to potent anxiolytic
activity. The fact that PNE reduced the percentage protected head
dips and stretch attend posture in the EPM also conﬁrm its ability to
reduce fear related behavior.
Oxidative stress contributes to cough in that reactive oxygen
species (ROS) have the potential of stimulating C-ﬁbers.29 In testing
the antioxidant effect, DPPH, 2, 2-diphenyl-1-picrylhydrazyl
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maximum absorption at 517 nm) and which accepts an electron or
hydrogen in the presence of a suitable free radical scavenger
(reducing agent) was used. From the IC50 values obtained, PNE and
ascorbic acid exhibited antioxidant activity. Oxidants can cause
damage by interacting with anti-proteases or other processes
leading to the development of chronic lung damage.30 Cough and
phlegm are symptoms frequently accompanying chronic obstruc-
tive pulmonary disease. This may be caused by oxidative
stressemediated inﬂammation and tissue damage.31 Intake of fruit
and vegetable, which are major sources of antioxidants, have been
associated with higher lung function and reduced symptoms of
cough with phlegm.32
It is to be noted that the mucolytic effect of acetylcysteine have
been attributed to their antioxidant activities33 and that gives an
indication of the fact that PNE may also have mucolytic activity.
There seems to be notable similarities between mucolytics and
expectorants: Mucolytics just like expectorants have been found to
be effective in productive cough34,35 also the model used in testing
expectorant effects i.e. the tracheal phenol red secretion has been
used in ascertaining mucolytic activity of various extracts.36 The
antioxidant effect established in this work can then be said to
contribute to the extracts ability to manage productive cough; a
property which is typical of expectorants. However this antioxidant
effect could also account for PNE's antitussive activity since reactive
oxygen species (ROS) are known activators of C-ﬁbers.
The mast cell stabilization, muco-suppressant, and antioxidant
effects were themost prominent effect of PNE even though it shows
signiﬁcant antimicrobial and anxiolytic activity. Preliminary
phytochemical screening of PNE indicated the presence of alka-
loids, tannins, steroids, glycosides, anthraquinones, and terpe-
noids2 some of which would have contributed to its
properties.37e39 A review of the medicinal uses, phytochemistry
and pharmacology of P. nitida has indicated that its alkaloids
(especially from the seed) have signiﬁcant antimicrobial, analgesic,
and anti-inﬂammatory properties40 while its coumestan glycosides
have antimicrobial activity; these which could make it useful as
antitussive.41 Alkaloids, phenolic compounds (tannins), glycosides,
saponins, sterols, and terpenoids has been reported to have mast
cell stabilizing effect.42e44 It is possible that the anxiolytic action
could be mediated by synergistic action of these phytochemicals as
seen in several studies.45 The lower dose of HIE (i.e. 100 mg/kg)
seemed to be more effective; giving more consistent results than
the higher doses (i.e. 300 and 500 mg/kg). This may not be sur-
prising since the extract may have several other components, some
of which may have antagonist effects to the agonist effect being
elicited; but would only be of signiﬁcance at higher doses i.e.
proportional to the dose administered.
5. Conclusion
The ethanolic seed extract of P. nitida has demonstrated very
signiﬁcant mast cell stabilizing, mucus suppressant and antioxidant
activity as well as substantial antibacterial and anxiolytic proper-
ties; all of which could contribute to its antitussive and expectorant
property.
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